Garini G, Mazzi A, Buzio C, Mutti A, Allegri L, Savazzi G, Borghetti A
Institute of internal Medicine and Nephrology, University of Parma, Italy.
Nephrol Dial Transplant. 1996 Apr;11(4):628-34. doi: 10.1093/oxfordjournals.ndt.a027351.
In this study we investigated whether the increase in proteinuria induced by an oral protein load may be prevented by the angiotensin-converting enzyme inhibitor (ACEI) captopril in patients with nephrotic syndrome, and whether the effects of captopril on renal haemodynamics and/or glomerular selectivity are comparable to those obtained with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin and the calcium-channel blocker (CaCB) nifedipine.
Twelve subjects underwent the following treatments: (1) low-protein meal (0.2 g protein/kg body wt), (2) high-protein meal (1.3 g protein/kg body wt), (3) high-protein meal plus oral captopril (50 mg), (4) high-protein meal plus oral nifedipine (10 mg), (5) high-protein meal plus oral indomethacin (50 mg). Urine and blood samples were obtained after meals and tested for total protein, immunoglobulin G and albumin. GFR and renal plasma flow (RPF) were calculated from iothalamate and p-aminohippuric acid clearances respectively.
Mean arterial pressure decreased significantly after both captopril (-4%, P = 0.001) and nifedipine (-5%, P = 0.0019). Compared with the low-protein meal, mean values of GFR and RPF increased significantly after the high-protein meal alone (+21%, P = 0.0002; +10%, P = 0.0491 respectively), and after captopril (+18%, P = 0.0025; +24%, P = 0.0034 respectively) or nifedipine administration (+30%, P = 0.0001; +21%, P = 0.0036 respectively), whereas they remained unchanged after the high-protein meal plus indomethacin administration. FF did not change significantly under the five experimental conditions. The increase in urinary protein excretion induced by the meat load (total protein +18%, P = 0.0102; albumin +26%, P = 0.0316; IgG +28%, P = 0.0203) was entirely blocked by both captopril and indomethacin, whereas it was further increased by nifedipine administration.
Both captopril and indomethacin, but not nifedipine, are able to prevent the increase in urinary protein excretion rate following a meat meal. The antiproteinuric effect of captopril is comparable to that of indomethacin, but the renal haemodynamic changes induced by these drugs differ considerably, because the filtration capacity and the renal functional reserve were preserved by captopril and decreased by indomethacin. The reduction in systemic blood pressure following administration of both captopril and nifedipine does not account for changes in proteinuria, since, with a similar degree of blood pressure lowering, urinary protein excretion is reduced by captopril and increased by nifedipine.
在本研究中,我们调查了血管紧张素转换酶抑制剂(ACEI)卡托普利是否可以预防肾病综合征患者口服蛋白质负荷诱导的蛋白尿增加,以及卡托普利对肾血流动力学和/或肾小球选择性的影响是否与非甾体抗炎药(NSAID)吲哚美辛和钙通道阻滞剂(CaCB)硝苯地平相当。
12名受试者接受了以下治疗:(1)低蛋白餐(0.2 g蛋白质/千克体重),(2)高蛋白餐(1.3 g蛋白质/千克体重),(3)高蛋白餐加口服卡托普利(50 mg),(4)高蛋白餐加口服硝苯地平(10 mg),(5)高蛋白餐加口服吲哚美辛(50 mg)。餐后采集尿液和血液样本,检测总蛋白、免疫球蛋白G和白蛋白。分别根据碘他拉酸盐和对氨基马尿酸清除率计算肾小球滤过率(GFR)和肾血浆流量(RPF)。
卡托普利(-4%,P = 0.001)和硝苯地平(-5%,P = 0.0019)治疗后平均动脉压均显著降低。与低蛋白餐相比,单独高蛋白餐后GFR和RPF的平均值显著增加(分别为+21%,P = 0.0002;+10%,P = 0.0491),卡托普利(分别为+18%,P = 0.0025;+24%,P = 0.0034)或硝苯地平给药后也显著增加(分别为+30%,P = 0.0001;+21%,P = 0.0036),而高蛋白餐加吲哚美辛给药后则保持不变。在五种实验条件下,滤过分数(FF)没有显著变化。肉类负荷诱导的尿蛋白排泄增加(总蛋白+18%,P = 0.0102;白蛋白+26%,P = 0.0316;IgG +28%,P = 0.0203)被卡托普利和吲哚美辛完全阻断,而硝苯地平给药后进一步增加。
卡托普利和吲哚美辛均能预防餐后尿蛋白排泄率的增加,而硝苯地平不能。卡托普利的抗蛋白尿作用与吲哚美辛相当,但这些药物引起的肾血流动力学变化差异很大,因为卡托普利可保留滤过能力和肾功能储备,而吲哚美辛则使其降低。卡托普利和硝苯地平给药后全身血压的降低并不能解释蛋白尿的变化,因为在血压降低程度相似的情况下,卡托普利可降低尿蛋白排泄,而硝苯地平则使其增加。